1 | A bill to be entitled |
2 | An act relating to animal control; amending s. |
3 | 381.0031, F.S.; requiring animal control officers, |
4 | wildlife officers, and disease laboratories to report |
5 | potential health risks to humans from animals; |
6 | amending s. 828.055, F.S.; providing for use of |
7 | additional prescription drugs for euthanasia and |
8 | chemical immobilization of animals; providing for |
9 | rulemaking to expand the list of additional |
10 | prescription drugs; providing that the Board of |
11 | Pharmacy or the Department of Health may revoke or |
12 | suspend a permit upon a determination that the |
13 | permittee or its employees or agents is using or has |
14 | used an authorized drug for other purposes or if a |
15 | permittee has committed specified violations; amending |
16 | s. 828.058, F.S.; restricting the use of intracardial |
17 | injection for euthanizing animals; prohibiting the |
18 | delivery of a lethal solution or powder by adding it |
19 | to food; providing an effective date. |
20 |
|
21 | Be It Enacted by the Legislature of the State of Florida: |
22 |
|
23 | Section 1. Section 381.0031, Florida Statutes, is amended |
24 | to read: |
25 | 381.0031 Report of diseases of public health significance |
26 | to department.- |
27 | (1) Any practitioner licensed in this state to practice |
28 | medicine, osteopathic medicine, chiropractic medicine, |
29 | naturopathy, or veterinary medicine; any hospital licensed under |
30 | part I of chapter 395; or any laboratory licensed under chapter |
31 | 483 that diagnoses or suspects the existence of a disease of |
32 | public health significance shall immediately report the fact to |
33 | the Department of Health. |
34 | (2) An animal control officer operating under s. 828.27, a |
35 | wildlife officer operating under s. 379.3311, or an animal |
36 | disease laboratory operating under s. 585.61 shall report |
37 | knowledge of any animal bite, diagnosis of disease in an animal, |
38 | or suspicion of a grouping or clustering of animals having |
39 | similar disease, symptoms, or syndromes that may indicate the |
40 | presence of a threat to humans. |
41 | (3)(2) Periodically The department shall periodically |
42 | issue a list of infectious or noninfectious diseases determined |
43 | by it to be a threat to public health and therefore of |
44 | significance to public health and shall furnish a copy of the |
45 | list to the practitioners listed in subsection (1). |
46 | (4)(3) Reports required by this section must be in |
47 | accordance with methods specified by rule of the department. |
48 | (5)(4) Information submitted in reports required by this |
49 | section is confidential, exempt from the provisions of s. |
50 | 119.07(1), and is to be made public only when necessary to |
51 | public health. A report so submitted is not a violation of the |
52 | confidential relationship between practitioner and patient. |
53 | (6)(5) The department may obtain and inspect copies of |
54 | medical records, records of laboratory tests, and other medical- |
55 | related information for reported cases of diseases of public |
56 | health significance described in subsection (3) (2). The |
57 | department shall examine the records of a person who has a |
58 | disease of public health significance only for purposes of |
59 | preventing and eliminating outbreaks of disease and making |
60 | epidemiological investigations of reported cases of diseases of |
61 | public health significance, notwithstanding any other law to the |
62 | contrary. Health care practitioners, licensed health care |
63 | facilities, and laboratories shall allow the department to |
64 | inspect and obtain copies of such medical records and medical- |
65 | related information, notwithstanding any other law to the |
66 | contrary. Release of medical records and medical-related |
67 | information to the department by a health care practitioner, |
68 | licensed health care facility, or laboratory, or by an |
69 | authorized employee or agent thereof, does not constitute a |
70 | violation of the confidentiality of patient records. A health |
71 | care practitioner, health care facility, or laboratory, or any |
72 | employee or agent thereof, may not be held liable in any manner |
73 | for damages and is not subject to criminal penalties for |
74 | providing patient records to the department as authorized by |
75 | this section. |
76 | (7)(6) The department may adopt rules related to reporting |
77 | diseases of significance to public health, which must specify |
78 | the information to be included in the report, who is required to |
79 | report, the method and time period for reporting, requirements |
80 | for enforcement, and required followup activities by the |
81 | department which are necessary to protect public health. |
82 | (8) This section does not affect s. 384.25. |
83 | Section 2. Section 828.055, Florida Statutes, is amended |
84 | to read: |
85 | 828.055 Controlled substances and legend drugs Sodium |
86 | pentobarbital; permits for use in euthanasia of domestic |
87 | animals.- |
88 | (1) The Board of Pharmacy shall adopt rules providing for |
89 | the issuance of permits authorizing the purchase, possession, |
90 | and use of sodium pentobarbital, and sodium pentobarbital with |
91 | lidocaine, tiletamine hydrochloride, alone or combined with |
92 | zolazepam (including Telazol), xylazine (including Rompun), |
93 | ketamine, acepromazine maleate (also acetylpromazine, and |
94 | including Atravet or Acezine), alone or combined with etorphine |
95 | (including Immobilon), and yohimbine hydrochloride, alone or |
96 | combined with atipamezole (including Antisedan) by county or |
97 | municipal animal control agencies or humane societies registered |
98 | with the Secretary of State for the purpose of euthanizing |
99 | injured, sick, or abandoned domestic animals which are in their |
100 | lawful possession or for the chemical immobilization of animals. |
101 | The rules shall set forth guidelines for the proper storage and |
102 | handling of these prescription drugs sodium pentobarbital and |
103 | sodium pentobarbital with lidocaine and such other provisions as |
104 | may be necessary to ensure that the drugs are used solely for |
105 | the purpose set forth in this section. The rules shall also |
106 | provide for an application fee not to exceed $50 and a biennial |
107 | renewal fee not to exceed $50. Upon formal, written request and |
108 | recommendation adopted in a public meeting by the Board of |
109 | Veterinary Medicine, the Board of Pharmacy may, by rule, add |
110 | controlled substances and legend drugs to the list of |
111 | prescription drugs in this subsection upon a finding that such |
112 | additions are necessary for the humane and lawful euthanasia of |
113 | injured, sick, or abandoned domestic animals or chemical |
114 | immobilization of animals. |
115 | (2) Any county or municipal animal control agency or any |
116 | humane society registered with the Secretary of State may apply |
117 | to the Department of Health Business and Professional Regulation |
118 | for a permit to purchase, possess, and use the prescription |
119 | drugs authorized under sodium pentobarbital or sodium |
120 | pentobarbital with lidocaine pursuant to subsection (1). Upon |
121 | certification by the Board of Pharmacy that the applicant meets |
122 | the qualifications set forth in the rules, the Department of |
123 | Health shall issue the permit. The possession and use of the |
124 | prescription drugs authorized under subsection (1) is limited to |
125 | those employees or agents of the permittee certified in |
126 | accordance with s. 828.058 or s. 828.27 while operating in the |
127 | scope of their respective official or employment duties with the |
128 | permittee. |
129 | (3) The department or the board may deny a permit, and |
130 | revoke, or suspend, or refuse to renew the permit of any |
131 | permittee, and may fine, place on probation, or otherwise |
132 | discipline any permittee, upon a determination that: |
133 | (a) The applicant or permittee or any of its employees or |
134 | agents is using or has used a prescription drug authorized under |
135 | subsection (1) sodium pentobarbital or sodium pentobarbital with |
136 | lidocaine for any purpose other than that set forth in this |
137 | section; or if the permittee fails to follow the rules of the |
138 | board regarding proper storage and handling. |
139 | (b) The applicant or permittee has failed to take |
140 | reasonable precautions against misuse, theft, loss, or diversion |
141 | of such prescription drugs; |
142 | (c) The applicant or permittee has failed to detect or to |
143 | report to the Department of Health a significant loss, theft, or |
144 | inventory shortage of such prescription drugs; |
145 | (d) The applicant or permittee has failed to follow the |
146 | rules of the Board of Pharmacy regarding proper storage and |
147 | handling of such prescription drugs; or |
148 | (e) The permittee has violated any provision of this |
149 | section, chapter 465, chapter 499, or any rule adopted under |
150 | those chapters. |
151 | (4) The Board shall adopt rules implementing subsection |
152 | (3), provided that disciplinary action may be taken only for a |
153 | substantial violation of the provisions of this section or the |
154 | rules adopted under this section. In determining the severity of |
155 | an administrative penalty to be assessed under this section, the |
156 | Department or the Board of Pharmacy shall consider: |
157 | (a) The severity of the violation; |
158 | (b) Any actions taken by the person to correct the |
159 | violation or to remedy complaints, and the timing of those |
160 | actions; and |
161 | (c) Any previous violations. |
162 | (5) The Department of Health may issue an emergency order |
163 | immediately suspending a permit issued under this section upon a |
164 | determination that a permittee, as a result of any violation of |
165 | any provision of this section or any rule adopted under this |
166 | section, presents a danger to the public health, safety, and |
167 | welfare. |
168 | (6) This section shall not apply to licensed pharmacies, |
169 | veterinarians, or health care practitioners operating within the |
170 | scope of the applicable professional act. |
171 | Section 3. Subsection (1) of section 828.058, Florida |
172 | Statutes, is amended to read: |
173 | 828.058 Euthanasia of dogs and cats.- |
174 | (1) Sodium pentobarbital, a sodium pentobarbital |
175 | derivative, or other agent the Board of Veterinary Medicine may |
176 | approve by rule shall be the only methods used for euthanasia of |
177 | dogs and cats by public or private agencies, animal shelters, or |
178 | other facilities which are operated for the collection and care |
179 | of stray, neglected, abandoned, or unwanted animals. A lethal |
180 | solution shall be used in the following order of preference: |
181 | (a) Intravenous injection by hypodermic needle; |
182 | (b) Intraperitoneal injection by hypodermic needle; |
183 | (c) If the dog or cat is unconscious with no corneal |
184 | reflex, intracardial injection by hypodermic needle; or |
185 | (d) Solution or powder added to food. |
186 | Section 4. This act shall take effect July 1, 2012. |